Seelos Therapeutics Inc.

10/25/2021 | Press release | Distributed by Public on 10/25/2021 12:14

Seelos Therapeutics Presents a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International Summit on Suicide Research